TECregen is pioneering thymus rejuvenation to address conditions driven by impaired T-cell responses. The company’s innovative approach focuses on revitalizing and expanding thymic epithelial cells (TECs) to replenish T cells and achieve durable improvements in immune function. By developing a pipeline of differentiated thymopoietic biologics, TECregen aims to strengthen immune recovery following transplantation or cytotoxic therapy, promote immune health, and enhance immune surveillance against cancer, ushering in a new era of immunotherapy.
Total raised: $12.53M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.03.2026 | Seed | $12.53M | LifeSpan V... |
Mentions in press and media 5
| Date | Title | Description |
| 03.03.2026 | New leadership for six Swiss startups | IMPLANZ provides cutting-edge technology tailored for implant testing and surgical planning on human bone samples. This innovative service offers a more efficient and cost-effective way for dentists to plan the implant surgery and for impl... |
| 14.01.2026 | TECregen Secures CHF 10 Million, Appoints Chairman to Propel Immune Rejuvenation | Swiss biotech TECregen secured CHF 10 million in seed funding. This investment propels its pioneering thymus-rejuvenating biologics. The goal: restore robust immune function, counter age-related decline, and tackle serious diseases. Boehrin... |
| 09.01.2026 | CHF 10 million seed funding and new board chair for TECregen | Alongside the Boehringer Ingelheim Venture Fund (BIVF) TECregen’s funding round saw participation from LifeSpan Vision Ventures, Carma Fund, EOS BioInnovation, High-Tech Gründerfonds (HTGF), the JFG Life Sciences Foundation of the Univers... |
| 08.01.2026 | TECregen Raises CHF 10 Million Seed Round, Names Dr. Bo Rode Hansen Chairman | Basel, Switzerland-based TECregen has raised CHF 10 million (approximately €10.7 million / $12.6 million) in seed financing to advance a new class of thymus-rejuvenating biologics aimed at restoring immune function by rejuvenating thymic ep... |
| - | TECregen | “Home :: TECregen” |